COVID-19 Research Paper Volume 13, Issue 14 pp 17961—17977

Two novel nomograms based on inflammatory cytokines or lymphocyte subsets to differentially diagnose severe or critical and Non-Severe COVID-19


Figure 6. Construction and validation of the nomogram by using inflammatory cytokines. The area under receiver operating characteristic curve values, the calibration curve and decision curve analysis in training set (AC) and in validation set (DF) are shown.